末梢動脈疾患の世界市場レポート 2025年

末梢動脈疾患の市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）7.7％で62億3,000万米ドルに成長します。予測期間の成長は、患者中心のケア、低侵襲手技の進歩、デジタルヘルスと遠隔モニタリング、再生医療アプローチ、標的薬物療法への注目によるものと考えられます。予測期間における主な動向としては、健康公平性への取り組み、ウェアラブルデバイスの統合、在宅リハビリの拡大、患者報告アウトカム（pros）、外来患者設定への移行などが挙げられます。

末梢動脈疾患の有病率の増加が、今後の末梢動脈疾患市場の成長を牽引すると予測されます。末梢動脈疾患は、心臓以外の動脈、主に足の動脈の狭窄や閉塞を伴い、血流の低下や合併症の可能性を引き起こします。末梢動脈疾患の治療は、症状を緩和し、運動能力を向上させ、重篤な合併症のリスクを下げることで、患者の全体的な幸福を高めることを目的としています。例えば、米国を拠点とする非営利団体である米国心臓協会（American Heart Association）は、2023年6月、米国では700万人から1,200万人、世界では約2億人がこの疾患に罹患していると推定しています。したがって、末梢動脈疾患の有病率の上昇が末梢動脈疾患市場の成長を促進しています。

市場成長の重要な促進要因は、高齢化人口の拡大です。人口に占める高齢者の割合が着実に増加するにつれて、末梢動脈疾患の主要な危険因子であるアテローム性動脈硬化症を開発する可能性が高まっています。アテローム性動脈硬化症は、脂肪沈着物の蓄積による動脈の狭窄または閉塞を伴い、手足への血流の減少につながります。世界保健機関（WHO）の2022年10月の報告書によると、世界の高齢化率は大幅に上昇し、2030年には世界の6人に1人が60歳以上になると予測されています。この人口動態の変化に伴い、80歳以上の高齢者も増加し、2020年から2050年の間に3倍になると予想されています。その結果、高齢化が末梢動脈疾患治療に対する需要を促進し、市場全体の成長に寄与すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の末梢動脈疾患PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の末梢動脈疾患市場：成長率分析
• 世界の末梢動脈疾患市場の実績：規模と成長, 2019-2024
• 世界の末梢動脈疾患市場の予測：規模と成長, 2024-2029, 2034F
• 世界の末梢動脈疾患総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の末梢動脈疾患市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 末梢血管形成術用バルーン
• 末梢ステント
• 末梢カテーテル
• 下大静脈（IVC）フィルター
• プラーク修正装置
• 血行動態血流調節装置
• 周辺機器アクセサリ
• 世界の末梢動脈疾患市場：薬剤別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脂質低下薬
• 血圧降下薬
• 血糖値調整薬
• 血栓予防薬
• 強心薬
• 血栓溶解剤
• 抗炎症剤
• 世界の末梢動脈疾患市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 非経口
• その他の投与経路
• 世界の末梢動脈疾患市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• その他のエンドユーザー
• 世界の末梢動脈疾患市場、タイプ別サブセグメンテーション：末梢血管形成術用バルーン、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬剤溶出バルーン
• 非薬剤溶出バルーン
• スコアリングバルーン
• カッティングバルーン
• 世界の末梢動脈疾患市場、タイプ別サブセグメンテーション：末梢ステント、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬剤溶出ステント
• ベアメタルステント
• カバー付きステント
• 世界の末梢動脈疾患市場、タイプ別サブセグメンテーション：末梢カテーテル、実績と予測, 2019-2024, 2024-2029F, 2034F
• シースイントロデューサー
• ガイドワイヤー
• 診断用カテーテル
• デリバリーカテーテル
• 世界の末梢動脈疾患市場、タイプ別サブセグメンテーション：下大静脈（IVC）フィルター、実績と予測, 2019-2024, 2024-2029F, 2034F
• 回収可能なIVCフィルター
• 永久IVCフィルター
• 世界の末梢動脈疾患市場、タイプ別サブセグメンテーション：プラーク修正デバイス、実績と予測, 2019-2024, 2024-2029F, 2034F
• アテローム切除装置
• レーザーアテローム切除装置
• 回転式アテレクトミー装置
• 世界の末梢動脈疾患市場、タイプ別サブセグメンテーション：血行動態血流調節装置、実績と予測, 2019-2024, 2024-2029F, 2034F
• 流れ転換装置
• 流量制限装置
• 世界の末梢動脈疾患市場、タイプ別サブセグメンテーション：周辺機器アクセサリ、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断用画像アクセサリ
• 介入処置用アクセサリキット
• サポートデバイス

第7章 地域別・国別分析

• 世界の末梢動脈疾患市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の末梢動脈疾患市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 末梢動脈疾患市場：競合情勢
• 末梢動脈疾患市場：企業プロファイル
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Vascular Solutions Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Koninklijke Philips N.V.（Royal Philips）
• B. Braun Melsungen AG.
• Terumo Corporation
• Edwards Lifesciences
• Becton Dickinson and Company（BD）
• Boston Scientific Corporation Incorporated
• Cook Group Incorporated
• Merit Medical Systems Inc.
• NuVasive Inc.
• Arjo AB
• Penumbra Inc.
• BIOTRONIK SE and Co. KG
• AngioDynamics Inc.
• Shockwave Medical Inc.
• Cardiovascular Systems Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 末梢動脈疾患市場2029：新たな機会を提供する国
• 末梢動脈疾患市場2029：新たな機会を提供するセグメント
• 末梢動脈疾患市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Peripheral Artery Disease (PAD) is a condition characterized by the narrowing or blockage of arteries, predominantly affecting the limbs, especially the legs. Atherosclerosis, marked by the buildup of fatty deposits (plaques) within artery walls, is the primary cause, leading to diminished blood flow to the affected areas.

Key products in the peripheral artery disease market encompass peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. Specifically, peripheral angioplasty balloons are medical devices engineered to expand narrowed or obstructed peripheral arteries. In the context of peripheral artery disease, these balloons play a crucial role in reopening arteries by inflating to compress plaques, ultimately widening the artery and restoring proper blood flow. Various pharmaceutical interventions involve lipid-lowering drugs, blood pressure-lowering drugs, glucose-regulating drugs, blood clot-preventing drugs, inotropes, thrombolytic agents, and anti-inflammatory agents. These medications are administered through diverse routes, including oral and parenteral, and cater to different end users such as hospitals, specialty clinics, and other healthcare facilities.

The peripheral artery disease market research report is one of a series of new reports from The Business Research Company that provides peripheral artery disease market statistics, including peripheral artery disease industry global market size, regional shares, competitors with a peripheral artery disease market share, detailed peripheral artery disease market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral artery disease industry. This peripheral artery disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peripheral artery disease market size has grown strongly in recent years. It will grow from $4.31 billion in 2024 to $4.63 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to the increasing prevalence of risk factors, growing aging population, clinical research and evidence-based medicine, awareness and screening programs, government healthcare initiatives

The peripheral artery disease market size is expected to see strong growth in the next few years. It will grow to $6.23 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to a focus on patient-centric care, advancements in minimally invasive procedures, digital health and remote monitoring, regenerative medicine approaches, and targeted drug therapies. Major trends in the forecast period include health equity initiatives, integration of wearable devices, expansion of home-based rehabilitation, patient-reported outcomes (pros), and shift to outpatient settings.

The increasing prevalence of peripheral artery diseases is anticipated to drive the growth of the peripheral artery disease market in the future. Peripheral artery disease involves the narrowing or blockage of arteries outside the heart, primarily in the legs, leading to reduced blood flow and potential complications. Treatment for peripheral artery disease aims to alleviate symptoms, improve mobility, and lower the risk of severe complications, thereby enhancing patients' overall well-being. For example, in June 2023, the American Heart Association, a U.S.-based nonprofit organization, estimated that between 7 to 12 million individuals in the United States and approximately 200 million people worldwide are affected by this condition. Therefore, the rising prevalence of peripheral artery diseases is propelling the growth of the peripheral artery disease market.

The significant driver for market growth is the expanding size of the aging population. As the proportion of older individuals in the population steadily rises, there is an associated increase in the likelihood of developing atherosclerosis, a major risk factor for peripheral artery disease. Atherosclerosis involves the narrowing or blockage of arteries due to the accumulation of fatty deposits, leading to reduced blood flow to the limbs. According to the World Health Organization's October 2022 report, the global aging population is expected to substantially increase, with 1 in 6 people worldwide projected to be aged 60 years or older by 2030. This demographic shift is accompanied by a rise in individuals aged 80 years or older, expected to triple between 2020 and 2050. Consequently, the aging population is anticipated to drive demand for peripheral artery disease treatments, contributing to the overall growth of the market.

The peripheral artery disease market is witnessing a significant trend towards technological advancements, with major companies adopting advanced surgical treatments to maintain their market positions. A notable example is Genesis MedTech Group, a Singapore-based medical device company, introducing the Chocolate Touch paclitaxel DCB catheter in November 2022. This percutaneous transluminal angioplasty (PTA) catheter is designed for treating patients with superficial femoral artery and popliteal artery disease. The Chocolate Touch drug-coated balloon, a pioneering catheter in the field, integrates therapeutic agent administration with a next-generation angioplasty platform for treating peripheral artery disease. It features pillow-such as structures covered with a therapeutic chemical, providing an alternative therapy to standard drug-coated balloon angioplasty. The unique design increases the balloon surface, enabling more effective medication delivery to the vessel wall and eliminating the need for permanent implants.

The growth of the peripheral artery disease market is expected to be propelled by increasing obesity rates. Obesity, characterized by the excess accumulation of body fat with negative health implications, is a significant contributing factor to peripheral artery disease (PAD). PAD involves the narrowing or blockage of blood vessels supplying blood to the legs, resulting in pain and difficulty walking. Notably, as of May 2022, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) reported that over 2 in 5 adults (42.4%) have obesity, with about 1 in 11 adults (9.2%) experiencing severe obesity. This upward trend in obesity rates is driving the demand for peripheral artery disease treatments.

In April 2023, Abbott Laboratories, a prominent US-based medical device company, acquired Cardiovascular Systems Inc. The acquisition, conducted for an undisclosed amount, expands and enriches Abbott's peripheral and coronary artery disease portfolio. Cardiovascular Systems Inc., a US-based medical device company specializing in manufacturing peripheral artery disease products, brings innovative atherectomy systems to further enhance Abbott's offerings in this medical domain.

Major companies operating in the peripheral artery disease market include Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

North America was the largest region in the peripheral artery disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the peripheral artery disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peripheral artery disease market consists of revenues earned by entities by providing peripheral artery disease management services and therapies such as diagnosis, angioplasty, atherectomy, lithoplasty, endovascular, vascular surgery, and rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The peripheral artery disease market also includes sales of guidewires, bare metal, drug-eluting, compression stockings, and exercise equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peripheral Artery Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peripheral artery disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peripheral artery disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peripheral artery disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Peripheral Angioplasty Balloons; Peripheral Stents; Peripheral Catheters; Inferior Vena Cava (IVC) Filters; Plaque Modification Devices; Hemodynamic Flow Alteration Devices; Peripheral Accessories
• 2) By Drugs: Lipid-Lowering Drugs; Blood Pressure Lowering Drugs; Glucose Regulating Drugs; Blood Clot Preventing Drugs; Inotropes; Thrombolytics Agents; Anti-Inflammatory Agents
• 3) By Route of Administration: Oral; Parenteral; Other Routes of Administration
• 4) By End Users: Hospitals; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons; Non-Drug-Eluting Balloons; Scoring Balloons; Cutting Balloons
• 2) By Peripheral Stents: Drug-Eluting Stents; Bare Metal Stents; Covered Stents
• 3) By Peripheral Catheters: Sheath Introducers; Guidewires; Diagnostic Catheters; Delivery Catheters
• 4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters; Permanent IVC Filters
• 5) By Plaque Modification Devices: Atherectomy Devices; Laser Atherectomy Devices; Rotational Atherectomy Devices
• 6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices; Flow Restriction Devices
• 7) By Peripheral Accessories: Diagnostic Imaging Accessories; Accessory Kits for Interventional Procedures; Support Devices
• Companies Mentioned: Cardinal Health Inc.; Vascular Solutions Inc.; Bayer AG; Abbott Laboratories; Medtronic plc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Peripheral Artery Disease Market Characteristics

3. Peripheral Artery Disease Market Trends And Strategies

4. Peripheral Artery Disease Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Peripheral Artery Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Peripheral Artery Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Peripheral Artery Disease Market Growth Rate Analysis
• 5.4. Global Peripheral Artery Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Peripheral Artery Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Peripheral Artery Disease Total Addressable Market (TAM)

6. Peripheral Artery Disease Market Segmentation

• 6.1. Global Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Peripheral Angioplasty Balloons
• Peripheral Stents
• Peripheral Catheters
• Inferior Vena Cava (IVC) Filters
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Peripheral Accessories
• 6.2. Global Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lipid-Lowering Drugs
• Blood Pressure Lowering Drugs
• Glucose Regulating Drugs
• Blood Clot Preventing Drugs
• Inotropes
• Thrombolytics Agents
• Anti-Inflammatory Agents
• 6.3. Global Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes of Administration
• 6.4. Global Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Other End Users
• 6.5. Global Peripheral Artery Disease Market, Sub-Segmentation Of Peripheral Angioplasty Balloons, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Eluting Balloons
• Non-Drug-Eluting Balloons
• Scoring Balloons
• Cutting Balloons
• 6.6. Global Peripheral Artery Disease Market, Sub-Segmentation Of Peripheral Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Eluting Stents
• Bare Metal Stents
• Covered Stents
• 6.7. Global Peripheral Artery Disease Market, Sub-Segmentation Of Peripheral Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sheath Introducers
• Guidewires
• Diagnostic Catheters
• Delivery Catheters
• 6.8. Global Peripheral Artery Disease Market, Sub-Segmentation Of Inferior Vena Cava (IVC) Filters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retrievable IVC Filters
• Permanent IVC Filters
• 6.9. Global Peripheral Artery Disease Market, Sub-Segmentation Of Plaque Modification Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Atherectomy Devices
• Laser Atherectomy Devices
• Rotational Atherectomy Devices
• 6.10. Global Peripheral Artery Disease Market, Sub-Segmentation Of Hemodynamic Flow Alteration Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flow Diversion Devices
• Flow Restriction Devices
• 6.11. Global Peripheral Artery Disease Market, Sub-Segmentation Of Peripheral Accessories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Imaging Accessories
• Accessory Kits for Interventional Procedures
• Support Devices

7. Peripheral Artery Disease Market Regional And Country Analysis

• 7.1. Global Peripheral Artery Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Peripheral Artery Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Peripheral Artery Disease Market

• 8.1. Asia-Pacific Peripheral Artery Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Peripheral Artery Disease Market

• 9.1. China Peripheral Artery Disease Market Overview
• 9.2. China Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Peripheral Artery Disease Market

• 10.1. India Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Peripheral Artery Disease Market

• 11.1. Japan Peripheral Artery Disease Market Overview
• 11.2. Japan Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Peripheral Artery Disease Market

• 12.1. Australia Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Peripheral Artery Disease Market

• 13.1. Indonesia Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Peripheral Artery Disease Market

• 14.1. South Korea Peripheral Artery Disease Market Overview
• 14.2. South Korea Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Peripheral Artery Disease Market

• 15.1. Western Europe Peripheral Artery Disease Market Overview
• 15.2. Western Europe Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Peripheral Artery Disease Market

• 16.1. UK Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Peripheral Artery Disease Market

• 17.1. Germany Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Peripheral Artery Disease Market

• 18.1. France Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Peripheral Artery Disease Market

• 19.1. Italy Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Peripheral Artery Disease Market

• 20.1. Spain Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Peripheral Artery Disease Market

• 21.1. Eastern Europe Peripheral Artery Disease Market Overview
• 21.2. Eastern Europe Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Peripheral Artery Disease Market

• 22.1. Russia Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Peripheral Artery Disease Market

• 23.1. North America Peripheral Artery Disease Market Overview
• 23.2. North America Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Peripheral Artery Disease Market

• 24.1. USA Peripheral Artery Disease Market Overview
• 24.2. USA Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Peripheral Artery Disease Market

• 25.1. Canada Peripheral Artery Disease Market Overview
• 25.2. Canada Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Peripheral Artery Disease Market

• 26.1. South America Peripheral Artery Disease Market Overview
• 26.2. South America Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Peripheral Artery Disease Market

• 27.1. Brazil Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Peripheral Artery Disease Market

• 28.1. Middle East Peripheral Artery Disease Market Overview
• 28.2. Middle East Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Peripheral Artery Disease Market

• 29.1. Africa Peripheral Artery Disease Market Overview
• 29.2. Africa Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Peripheral Artery Disease Market Competitive Landscape And Company Profiles

• 30.1. Peripheral Artery Disease Market Competitive Landscape
• 30.2. Peripheral Artery Disease Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Vascular Solutions Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis

31. Peripheral Artery Disease Market Other Major And Innovative Companies

• 31.1. Koninklijke Philips N.V. (Royal Philips)
• 31.2. B. Braun Melsungen AG.
• 31.3. Terumo Corporation
• 31.4. Edwards Lifesciences
• 31.5. Becton Dickinson and Company (BD)
• 31.6. Boston Scientific Corporation Incorporated
• 31.7. Cook Group Incorporated
• 31.8. Merit Medical Systems Inc.
• 31.9. NuVasive Inc.
• 31.10. Arjo AB
• 31.11. Penumbra Inc.
• 31.12. BIOTRONIK SE and Co. KG
• 31.13. AngioDynamics Inc.
• 31.14. Shockwave Medical Inc.
• 31.15. Cardiovascular Systems Inc.

32. Global Peripheral Artery Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peripheral Artery Disease Market

34. Recent Developments In The Peripheral Artery Disease Market

35. Peripheral Artery Disease Market High Potential Countries, Segments and Strategies

• 35.1 Peripheral Artery Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Peripheral Artery Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Peripheral Artery Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer